Pharming Group N.V. at its EGM approved the appointment of Dr. Richard Peters as Non-Executive director for a period of four years. As a result, Dr. Peters succeeds Mr. Paul Sekhri as Chair of the Board of Directors with immediate effect. During his tenure as Chairman, Paul accomplished many strategic objectives and leaves Pharming in a strong position for his successor, Dr. Richard Peters.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.873 EUR | -0.68% | -0.40% | -15.32% |
05-08 | Pharming Group N.V. Provides Revenue Guidance for 2024 | CI |
05-08 | Pharming Group N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.32% | 636M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group N.V. Appoints Richard Peters as Non-Executive Director